Abstract
This paper presents the R package pocrm for implementing and simulating the partial order continual reassessment method (PO-CRM; [1,2]) in Phase I trials of combinations of agents. The aim of this article is to illustrate, through examples of the pocrm package, how the PO-CRM works and how its operating characteristics can inform clinical trial investigators. This should promote the use of the PO-CRM in designing and conducting dose-finding Phase I trials of combinations of agents.
Keywords:
Continual reassessment method; Dose finding; Drug combination; Partial ordering; Phase I trials.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Cancer Vaccines / administration & dosage
-
Clinical Trials, Phase I as Topic / statistics & numerical data*
-
Computer Simulation
-
Freund's Adjuvant / administration & dosage
-
Humans
-
Lipids / administration & dosage
-
Maximum Tolerated Dose
-
Melanoma / therapy
-
Neoplasms / drug therapy*
-
Software*
-
Toll-Like Receptors / agonists
Substances
-
Antineoplastic Agents
-
Cancer Vaccines
-
Lipids
-
Toll-Like Receptors
-
incomplete Freund's adjuvant
-
Freund's Adjuvant